Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4451
Lyell Immunopharma
LYEL
$423M
| $58.9K | ﹤0.01% |
6,013
+1,298
| +28% | +$17.3K |
2022 Q1
18 quarters
|
|
4452
Nomura Holdings
NMR
$28.4B
| $58.7K | ﹤0.01% |
6,002
+4,380
| +270% | +$43.4K |
2026 Q2
1 quarter
|
|
4453
Angel Oak Mortgage REIT
AOMR
$145M
| $58.3K | ﹤0.01% |
7,980
+5,370
| +206% | +$45.9K |
2022 Q1
18 quarters
|
|
4454
CALL
Apollo Global Management
APO
$73.4B
| $58K | ﹤0.01% |
500
| – | – |
2026 Q2
1 quarter
|
|
4455
Evolution Petroleum
EPM
$135M
| $57.8K | ﹤0.01% |
16,323
+7,306
| +81% | +$26.8K |
2022 Q3
16 quarters
|
|
4456
Collective Mining Ltd
CNL
$1.27B
| $57.6K | ﹤0.01% |
+4,699
| New | +$64.6K |
2026 Q3
0 quarters
|
|
4457
Espey Mfg & Electronics Corp
ESP
$141M
| $57.3K | ﹤0.01% |
933
+397
| +74% | +$24.6K |
2026 Q1
2 quarters
|
|
4458
Consumer Portfolio Services
CPSS
$218M
| $57.2K | ﹤0.01% |
6,244
+2,927
| +88% | +$27.3K |
2022 Q2
17 quarters
|
|
4459
CoinShares PLC
CSHR
$494M
| $57.1K | ﹤0.01% |
+11,498
| New | +$57.5K |
2026 Q3
0 quarters
|
|
4460
Inspired Entertainment
INSE
$122M
| $57.1K | ﹤0.01% |
16,605
+11,786
| +245% | +$71.1K |
2022 Q2
17 quarters
|
|
4461
Ampco-Pittsburgh
AP
$154M
| $56.9K | ﹤0.01% |
6,432
+3,091
| +93% | +$26.2K |
2026 Q1
2 quarters
|
|
4462
Equillium
EQ
$114M
| $56.9K | ﹤0.01% |
35,000
| – | – |
2026 Q2
1 quarter
|
|
4463
Zentalis Pharmaceuticals
ZNTL
$180M
| $56.9K | ﹤0.01% |
20,529
-138,327
| -87% | -$558K |
2022 Q1
18 quarters
|
|
4464
DBV Technologies S.A. American Depositary Shares
DBVT
$741M
| $56.3K | ﹤0.01% |
4,784
-2,414
| -34% | -$33.5K |
2026 Q1
2 quarters
|
|
4465
Compass Therapeutics
CMPX
$148M
| $56.1K | ﹤0.01% |
53,983
+3,586
| +7% | +$7.39K |
2022 Q3
16 quarters
|
|
4466
MediWound
MDWD
$200M
| $56K | ﹤0.01% |
4,069
+2,337
| +135% | +$32.4K |
2024 Q2
9 quarters
|
|
4467
Innovator US Equity Ultra Buffer ETF March
UMAR
$142M
| $56K | ﹤0.01% |
1,298
| – | – |
2025 Q2
5 quarters
|
|
4468
Spruce Biosciences
SPRB
$135M
| $55.9K | ﹤0.01% |
1,150
+476
| +71% | +$24.1K |
2026 Q2
1 quarter
|
|
4469
Turkcell
TKC
$4.18B
| $55.8K | ﹤0.01% |
+11,303
| New | +$61.4K |
2026 Q3
0 quarters
|
|
4470
FundStrat Granny Shots US Large Cap ETF
GRNY
$4.23B
| $55.7K | ﹤0.01% |
2,000
| – | – |
2026 Q1
2 quarters
|
|
4471
Transcontinental Realty Investors
TCI
$431M
| $55.6K | ﹤0.01% |
1,250
+1,096
| +712% | +$44.7K |
2022 Q2
17 quarters
|
|
4472
BRC Group Holdings
RILY
$133M
| $55.4K | ﹤0.01% |
11,338
+3,964
| +54% | +$27.2K |
2016 Q3
40 quarters
|
|
4473
DoubleDown Interactive
DDI
$779M
| $55.4K | ﹤0.01% |
4,165
+2,965
| +247% | +$36.3K |
2026 Q2
1 quarter
|
|
4474
NLI Holdings
NL
$360M
| $55K | ﹤0.01% |
7,898
+3,794
| +92% | +$24.3K |
2016 Q3
40 quarters
|
|
4475
Greenwich LifeSciences
GLSI
$243M
| $54.9K | ﹤0.01% |
3,044
+2,194
| +258% | +$36.6K |
2024 Q2
9 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.